Health and Wellness Coaching to Improve Adherence to Healthy Habits and Treatment Plans in Papillary and Follicular Thyroid Cancer Survivors

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorMayo Clinic

About this trial

This clinical trial evaluates the impact of a patient-centered health and wellness coaching (HWC) intervention on adherence to treatment plans and healthy lifestyle practices in patients with papillary or follicular thyroid cancer. Treatment for thyroid cancer often involves surgery, radioactive iodine and/or lifelong levothyroxine with regular monitoring of thyroid stimulating hormone levels. Despite strong survival rates, patients frequently report fatigue, cognitive issues, mood changes, and disruptions in daily life. Treatment burden and psychosocial strain often impair the ability to follow the treatment plan and healthy lifestyle. Studies have shown that HWC motivates patients to take ownership and accountability to perform positive and healthy behavioral changes. HWC may have a positive impact on health-related goal-setting processes and improve self-care and healthcare outcomes in certain settings. It is not yet known how HWC impacts thyroid cancer patients. Incorporating HWC into survivorship care may improve adherence to treatment plans and healthy lifestyle practices in patients with papillary or follicular thyroid cancer.

Eligibility criteria

Qualifiers

Adults ≥ 18 years

Histologically confirmed papillary or follicular thyroid carcinoma

Status post total thyroidectomy ± radioactive iodine therapy

Receiving levothyroxine monotherapy (no triiodothyronine [T3] or desiccated thyroid products)

Disqualifiers

Medullary or anaplastic thyroid carcinoma

Current systemic therapy for thyroid or other cancers

Cognitive or psychiatric impairment precluding participation

Inability to complete study procedures

Trial design

Treatments tested in this trial

  • Counseling
  • Interview
  • Questionnaire Administration

Treatment groups

20 Participants
are divided into 1 treatment group

Sponsors and collaborators